Latest Articles
Uterine Cancer Survival Varies Widely by Race Across US - Medscape
Uterine Cancer Survival Varies Widely by Race Across US Medscape
Published: May 7, 2025, 12:27 p.m.
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - The Manila Times
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids The Manila Times
Published: May 7, 2025, 12:24 p.m.
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - PR Newswire
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids PR Newswire
Published: May 7, 2025, noon
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - 스페셜타임스
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids 스페셜타임스
Published: May 7, 2025, noon
Daewon Pharm’s uterine fibroid drug meets primary endpoint in P2 trial - koreabiomed.com
Daewon Pharm’s uterine fibroid drug meets primary endpoint in P2 trial koreabiomed.com
Published: May 7, 2025, 6:51 a.m.
Research reveals early warning signs for uterine health - Medical Xpress
Research reveals early warning signs for uterine health Medical Xpress
Published: April 25, 2025, 3:07 p.m.
Research Reveals Early Warning Signs for Uterine Health - University of Missouri School of Medicine
Research Reveals Early Warning Signs for Uterine Health University of Missouri School of Medicine
Published: April 24, 2025, noon
MYB Proto-Oncogene Like 2 Identified as a Biomarker for Uterine Corpus Endometrial Carcinoma: evidence from Bioinformatics and Clinical Validation - Frontiers
MYB Proto-Oncogene Like 2 Identified as a Biomarker for Uterine Corpus Endometrial Carcinoma: evidence from Bioinformatics and Clinical Validation Frontiers
Published: April 23, 2025, 2:47 p.m.
Intrauterine infusion of autologous platelet-rich plasma modulates endometrial immune status and improves pregnancy outcomes in patients with persistent chronic endometritis - Frontiers
Intrauterine infusion of autologous platelet-rich plasma modulates endometrial immune status and improves pregnancy outcomes in patients with persistent chronic endometritis Frontiers
Published: April 23, 2025, 10:28 a.m.
Mayo Clinic Q and A: Uterine polyps rarely are cancerous - Mayo Clinic News Network
Mayo Clinic Q and A: Uterine polyps rarely are cancerous Mayo Clinic News Network
Published: April 21, 2025, 3 p.m.
Link copied to clipboard!